(Press-News.org) A new listening device, developed by scientists from the University of Southampton, is being used to monitor the effectiveness of the treatment of kidney stones - saving patients unnecessary repeat therapy and x-ray monitoring.
If kidney stones cannot be dissolved by drugs, the favoured procedure is lithotripsy. Lithotripsy works by focusing thousands of shock waves onto the kidney stones in an effort to break them into pieces small enough to urinate out of the body or be dissolved by drugs.
However, it is difficult to discover exactly when the treatment has succeeded in breaking the stone and patients frequently have to experience more shocks than necessary, or be sent home when an insufficient number of shocks have been delivered to break the stone.
The new 'Smart stethoscope' has been developed by a team from the University's Faculty of Engineering and the Environment in collaboration with Guy's and St Thomas' Foundation Trust (GSTT) and Precision Acoustics Ltd. The programme was led by Professor Tim Leighton from the University's Institute of Sound and Vibration Research (ISVR).
The 'Smart stethoscope' is placed on a patient's skin as they undergo shock wave treatment for kidney stones and assesses whether the treatment is working. It listens to the echoes, which reverberate around the body after each shock wave hits the stone. The device is now being used clinically at the London hospitals of GSTT.
Professor Leighton says: "It's an imperfect analogy, but consider a railwayman walking along the length of a train, hitting the metal wheels with a hammer, If the wheel rings nicely, he knows that it's not cracked. If the wheel is cracked, it gives a duller sound.
"We are looking for the stone to go from being intact at the start of treatment (when it will give a nice ring "tick" sound) to being fragmented at the end of the treatment (when it will give a duller "tock" sound)."
Professor Leighton's research, which includes the computational fluid dynamics (CFD) use to inform judgements underpinning the invention of the smart stethoscope, is published in the latest issue of the Royal Society journal Proceedings of the Royal Society A.
Dr Fiammetta Fedele of GSTT said: "Professor Leighton's CFD predictions of the acoustic signals emitted when bubbles collapse against kidney stones during SWL led (through collaboration with GSTT and Precision Acoustics Ltd.) to a £5,000 passive acoustic sensor. When placed on the patient's skin this sensor diagnoses successful SWL treatments (with 94.7 per cent accuracy in clinical trials, compared to the 36.8 per cent achieved by clinicians with the current state-of-the-art equipment suite). An accurate diagnostic is needed to conform with the 2004 'The NHS improvement Plan: putting people at the heart of public services' of reducing the 'patient pathway', because currently 30-50 per cent of SWL patients require re-treatment and an unknown are overdosed."
The NHS is trialling the smart stethoscope as part of major plans to reduce inaccurate diagnoses and ineffective treatments, and so far GSTT has used the sensor on over 200 patients.
In subsequent use of the device, GSTT have found it has the additional benefit that it can detect whether the treatment will work, before the stage when any possible adverse side effects from the treatment are likely to have occurred. This allows ready identification of those patients who should not receive this treatment, but whom should be referred to some other therapy to treat their kidney stones.
Professor Leighton says: "The research in the paper describes how we reached the decision stage to move from relatively inexpensive computer simulation to much more costly clinical trials in collaboration with NHS. This is a critical stage in R+D of this type – if the move is taken too early, the expensive clinical trials do not have adequate underpinning science and engineering, resources are wasted, and the eventual patient benefit is delayed. But conversely if the decision to move is taken too late, then the positive benefits to patients can be delayed for years.
"The research in this paper also defines the parameters needed by our commercial partner (Precision Acoustics Ltd.) to build a robust clinical sensor from the laboratory version we had made. It has taken seven years of research and development to arrive at a clinical device from the initial fundamental research done in the early 1990's by Dr Coleman of GSTT and myself. It was hard work with a great team, and seeing the positive patient outcomes now makes it all worthwhile. "
INFORMATION:
'Smart stethoscope' advance in monitoring treatment of kidney stones
2012-12-12
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Rice, Texas Children's team creates biocompatible patch to heal infants with birth defects
2012-12-12
A painstaking effort to create a biocompatible patch to heal infant hearts is paying off at Rice University and Texas Children's Hospital.
The proof is in a petri dish in Jeffrey Jacot's lab, where a small slab of gelatinous material beats with the rhythm of a living heart.
Jacot, lead author Seokwon Pok, a postdoctoral researcher at Rice, and their tissue-engineering colleagues have published the results ofyears of effort to produce a material called a bioscaffold that could be sutured into the hearts of infants suffering from birth defects. The scaffold, seeded with ...
Climate modelers see possible warmer, wetter Northeast winters by 2070
2012-12-12
AMHERST, Mass. – A new high-resolution climate study by University of Massachusetts Amherst climate scientists, the first to apply regional climate models to examine likely near-term changes in temperature and precipitation across the Northeast United States, suggests temperatures are going to be significantly warmer in all seasons in the next 30 years, especially in winter. Also, they project that winters will be wetter, with more rain likely than snow.
Writing in the current issue of the Journal of Geophysical Research, Michael Rawlins and Raymond Bradley of the Climate ...
UGA researchers find algal ancestor is key to how deadly pathogens proliferate
2012-12-12
Athens, Ga. – Long ago, when life on Earth was in its infancy, a group of small single-celled algae propelled themselves through the vast prehistoric ocean by beating whip like tails called flagella. It's a relatively unremarkable tale, except that now, more than 800 million years later, these organisms have evolved into parasites that threaten human health, and their algal past in the ocean may be the key to stopping them.
The organisms are called apicomplexa, but people know them better as the parasites that cause malaria and toxoplasmosis, serious diseases that infect ...
Ultra-short laser pulses control chemical processes
2012-12-12
This press release is available in German.
Chemical reactions occur so quickly that it is completely impossible to observe their progress or to control them using conventional methods. However, new developments in electrical engineering and quantum technology enable us to achieve a more exact understanding and improved control of the behaviour of atoms and molecules. At the TU Vienna, scientists have succeeded in influencing the splitting of large molecules with up to ten atoms using ultra-short laser pulses.
The flash of light which splits molecules
Splitting a ...
Older and younger chronic leukemia patients may need different therapy
2012-12-12
People who develop chronic lymphocytic leukemia (CLL) are typically age 65 and older, but participants in CLL clinical trials are usually several years younger;
The age of CLL patients is not usually considered when determining treatment;
This study suggests that older and younger CLL patients require different therapy.
COLUMBUS, Ohio – Doctors should use different therapies when treating older and younger patients with chronic lymphocytic leukemia, according to a new study led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. ...
Researchers shed light on the workings of the body's immune response
2012-12-12
Researchers from Queen Mary, University of London have discovered that two proteins which are believed to play a key role in controlling the body's immune response are found in lower levels in T lymphocytes from patients with multiple sclerosis (MS).
The study found that MS patients' T lymphocytes – types of white blood cells which play an important role in the immune system – were defective at producing the proteins and that this was associated with increased levels of molecules which promote inflammation. The findings are reported in the Journal of Immunology¹.
The ...
Can algae-derived oils support large-scale, low-cost biofuels production?
2012-12-12
New Rochelle, NY, December 12, 2012—ExxonMobil and many other energy companies are investing hundreds of millions of dollars to develop transportation biofuels from renewable resources such as the oil or hydrocarbons produced by microalgae. As global supplies of fossil fuels continue to shrink, biofuels derived from algae represent one promising source of low-cost, scalable renewable energy. The feasibility and economic projections for large-scale biofuels production from microalgae are examined in a Review article and accompanying Commentary published in Disruptive Science ...
Novel test identifies patients most likely to benefit from ALK inhibition therapy
2012-12-12
Philadelphia, PA, December 12, 2012 – Approximately one in 20 patients with non-small cell lung carcinoma (NSCLC) has chromosomal aberrations targeting the anaplastic lymphoma kinase (ALK) gene. This has considerable implications for treatment because these patients are highly responsive to ALK-specific kinase inhibitors such as crizotinib. However, current diagnostic tests have limitations. Researchers have now developed and tested a promising new method for screening ALK fusions in NSCLC. This new diagnostic assay offers a cost-effective and easy-to-perform alternative ...
Frog-in-bucket-of-milk folklore leads to potential new antibiotics
2012-12-12
Following up on an ancient Russian way of keeping milk from going sour — by putting a frog in the bucket of milk — scientists have identified a wealth of new antibiotic substances in the skin of the Russian Brown frog. The study appears in ACS' Journal of Proteome Research.
A. T. Lebedev and colleagues explain that amphibians secrete antimicrobial substances called peptides through their skin. These compounds make up the majority of their skin secretions and act as a first line of defense against bacteria and other microorganisms that thrive in the wet places frogs, toads, ...
A promising clinical trial to reduce the severity of autistic disorders
2012-12-12
This press release is available in French.
Although this therapy is not curative, it nevertheless reduced the autistic disorders' severity in three-quarters of the children. The researchers have filed a request for authorisation to perform a multi-centre European clinical trial in order to determine more precisely the population concerned by this therapy.
Details of this work have been published in the Translational Psychiatry review dated 11 December 2012.
Contribution made by the fundamental research on neuronal chloride
Previous work carried out by the team of ...